Fundraising FoxCelladon
La Jolla, US · 1 known investors
Find your way into Celladon
Sign up to see every warm intro you have to Celladon
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Celladon team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
RL
Rebecque LabaExecutive
KZ
Krisztina ZseboChief Executive Officer2004–2015Krisztina Zsebo is a biotechnology executive with 34 years of experience in drug discovery, development, and commercialization at companies including Amgen, ALZA, Connetics, and Cell Genesys/Xenotech, where she contributed to the development of major biopharmaceuticals including EPOGEN and NEUPOGEN; she holds a PhD in Biochemistry from UC Berkeley, has published 113 peer-reviewed papers, and holds 34 issued patents with 26 additional pending.
Board
AE
Andrew E. SenyeiBoard director
DO
Daniel OmsteadBoard director
BD
Barbara DaltonBoard director
JF
Joshua FunderBoard director
JK
Johan KordelBoard director
LS
Lauren SilvermanBoard director
Investors · 1
Pfizer Venture Investmentsreported$5M – $20M
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$20.8M disclosed across 2 rounds · 2012–2016
▶$3MraisedApr 2016 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedApr 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Nina KjellsonDirector
- Edgar G. EnglemanDirector
- Joanne QuanExecutive Officer
- Charles BramlageDirector
- Thomas J. DietzDirector
- James H. WelchExecutive Officer
- James P. ShafferExecutive Officer
- Jeffrey S. GlennDirector
- David A. CoryExecutive Officer, Director
- Eduardo Bruno MartinsExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17.8MraisedFeb 2012 · 13 investors · BiotechnologyRule 506(b)
▶$17.8MraisedFeb 2012 · 13 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Andrew E. SenyeiDirector
- Daniel OmsteadDirector
- Barbara DaltonDirector
- Rebecque LabaExecutive Officer
- Joshua FunderDirector
- Krisztina ZseboExecutive Officer, Director
- Johan KordelDirector
- Lauren SilvermanDirector
- Offering amount
- $61.3M
- Amount sold
- $17.8M
- First sale
- Jan 2012
- Incorporated
- Corporation, California
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Celladon's investors?
- Celladon's investors include Pfizer Venture Investments.
- How much funding has Celladon raised?
- Celladon has disclosed $20.8M raised across 2 rounds.
- Where is Celladon headquartered?
- Celladon is headquartered in La Jolla, US.